MorphoSys Publikationen

Im Folgenden finden Sie eine Auswahl wissenschaftlicher Veröffentlichungen rund um MorphoSys’ Technologien und damit verbundene Forschungsprojekte. Die meisten Veröffentlichungen sind nur in englischer Sprache verfügbar.



  1. Molecular basis of in vitro affinity maturation and functional evolution of a neutralizing anti-human GM-CSF antibody
    Eylenstein, R; et al mAbs
  2. Solution Equilibrium Titration for High-
    Della Ducata, D; Journal of Biomolecular Screening 2015, Vol. 20(10)


  1. "Characterization and screening of IgG binding to the neonatal Fc receptor"
    Neuber, T. et al.; MAbs. 2014 Jul 1;6(4). [Epub ahead of print]
  2. MOR103, a human monoclonal antibody to granulocyte–macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial
    Behrens, F; et al. Ann Rheum Dis 2014


  1. "A fully synthetic human Fab antibody library based on fixed VH/VL framework pairings with favorable biophysical properties"
    Tiller, T. et al.; MAbs. 2013 Apr 9;5(3). [Epub ahead of print]
  2. "An automated immunoassay for early specificity profiling of antibodies"
    Frese, K. et al.; MAbs. 2013 Feb 14;5(2). [Epub ahead of print]


  1. "Granulocyte macrophage-colony stimulating factor is a key mediator in experimental osteoarthritis pain and disease development"
    Cook, AD. et al,; Arthrithis research & therapy, Epub 2012 Sep 20
  2. "Granulocyte-macrophage colony-stimulating factor is a key mediator in inflammatory and arthritic pain"
    Cook, AD. et al.; Annals of the rheumatic diseases, Epub 2012 Jul 24
  3. "Phage Display"
    Petropoulos, K.; Methods in Molecoular Biology, Epub 2012 June
  4. "Evaluation of combination therapies with MOR00208, an Fc-enhanced humanized CD19 antibody, in models of lymphoma"
    Winderlich, M. et al; Presentation given at the 2012 ASCO Annual Meeting, Jun 1-5; citation: Journal of Clinical Oncology 30: 2012 (suppl; abstr 6574)


  1. "Gantenerumab: A Novel Human Anti-Aβ Antibody Demonstrates Sustained Cerebral Amyloid-β Binding and Elicits Cell-Mediated Removal of Human Amyloid-β"
    Bohrmann, B. et al; Journal of Alzheimer's Disease, Epub 2011 Sep 28
  2. "Antibodies in Metabolic Diseases"
    Ahrens, B.; New Biotechnology, 2011 Sep, 28 (5)
  3. "HuCAL PLATINUM, a Synthetic Fab Library Optimized for Sequence Diversity and Superior Performance in Mammalian Expression Systems"
    Prassler, J. et al; Journal of Molecular Biology, Epub 2011 Aug 12
  4. "Synthetic Antibodies Designed on Natural Sequence Landscapes"
    Zhai, W. et al.; Journal of Molecular Biology, Epub 2011 Jul 23
  5. "Effect of MOR202, a human CD38 antibody, in combination with lenalidomide and bortezomib, on bone lysis and tumor load in a physiologic model of myeloma"
    Endell, J. et al.; Presentation given at the 2011 ASCO Annual Meeting, Jun 3-7; citation: Journal of Clinical Oncology 29: 2011 (suppl; abstr 8078)